Juliet Clare Gray

Research

Research groups

Member of:

Research interests

Developing novel immunotherapies for neuroblastoma

Research projects

Active projects

J. Gray, Understanding and improving the mechanism of action of monoclonal antibody therapies in neuroblastoma

Researchers:

Doctor Juliet Gray

Understanding and improving the mechanism of action of monoclonal antibody therapies in neuroblastoma

Researchers:

Doctor Juliet Gray

Understanding and improving the mechanism of action of anti-GD2 monoclonal antibody therapy in neuroblastoma

Researchers:

Doctor Juliet Gray

Professor Tony Williams ,

Professor Andy Davies

Sponsor: Childrens Cancer and Leukaemia Group

Evaluating the efficacy of Enhancer of Zeste Homolog 2 (EZH2) inhibitors in combination with anti-GD2/isotretinoin for the treatment of high-risk neuroblastoma: a pre-clinical study

Researchers:

Doctor Zoë Walters

Doctor Juliet Gray ,

Doctor Jane Gibson

Sponsor: Childrens Cancer and Leukaemia Group

Cancer Research UK Southampton Centre - Non-Clinical Training Award

Researchers:

Professor Peter Johnson

Professor Diana Eccles ,

Professor Tim Underwood ,

Professor Stephen Beers ,

Professor Jon Strefford ,

Doctor Jeremy Blaydes ,

Professor Edd James ,

Professor John Primrose ,

Professor Gareth Thomas ,

Professor Ramsey Cutress ,

Professor Francesco Forconi ,

Professor Freda Stevenson ,

Professor Alex Mirnezami ,

Professor Mark Cragg ,

Professor Aymen Al-Shamkhani ,

Professor Anneke Lucassen ,

Professor Simon Crabb ,

Doctor Juliet Gray ,

Doctor Sean Lim ,

Doctor Ellen Copson ,

Professor Graham Packham

Sponsor: Cancer Research UK

Evaluating the efficacy of Enhancer of Zeste Homolog 2 (EZH2) inhibitors in combination with anti- GD2/isotretinoin for the treatment of high-risk neuroblastoma: a pre-clinical study

Researchers:

Doctor Zoë Walters

Doctor Jinhui Gao ,

Doctor Juliet Gray

Identifying the underlying molecular mechanisms and alterations of the high-risk neuroblastoma tumour microenvironment in TH-MYCN mice treated with anti-GD2 antibody therapy

Researchers:

Doctor Jade Forster

Doctor Juliet Gray ,

Doctor Jane Gibson ,

Doctor Zoë Walters

Sponsor: Wessex Medical Research

Investigating The Role Of Enhancer Of Zeste Homolog 2 (EZH2) Inhibition On Natural Killer Cell Mediated Antitumour Effects In High-risk Neuroblastoma

Researchers:

Doctor Jinhui Gao

Doctor Juliet Gray ,

Doctor Zoë Walters

Sponsor: Neuroblastoma UK

Completed projects

Dr J Gray: Innovation Fund M22: Optimising Therapy with Immunostimulatory Monoclonal Antibodies in Pre-Clinical Neuroblastoma Models

Researchers:

Doctor Juliet Gray

Sponsor: Wessex Medical Research

MINIVAN trial

Researchers:

Doctor Juliet Gray

Gray SPARKS Manipulating FC Gamma Receptors

Researchers:

Doctor Juliet Gray

Professor Stephen Beers ,

Professor Mark Cragg

Sponsor: Sparks Children's Medical Research Charity

Dr Gray: C8574/A11781 Optimising therapeutic anti-tumour immunity in pre-clinical neuroblastoma models by combining immunostimulatory monoclonal antibodies and survivin vaccines

Researchers:

Doctor Juliet Gray

Sponsor: Cancer Research UK

Dr Gray: Retinoic acid and neurobastoma

Researchers:

Doctor Juliet Gray

Sponsor: Wessex Cancer Trust

Dr J. Gray: PCV in ALL study

Researchers:

Doctor Juliet Gray

Sponsor: National Institute of Health and Care Research

Cancer Research UK Southampton Centre - Clinical Training Award

Researchers:

Professor Peter Johnson

Professor Diana Eccles ,

Professor Stephen Beers ,

Professor Tim Underwood ,

Professor Jon Strefford ,

Doctor Jeremy Blaydes ,

Professor Edd James ,

Professor John Primrose ,

Professor Gareth Thomas ,

Professor Ramsey Cutress ,

Professor Francesco Forconi ,

Professor Freda Stevenson ,

Professor Alex Mirnezami ,

Professor Mark Cragg ,

Professor Aymen Al-Shamkhani ,

Professor Anneke Lucassen ,

Professor Simon Crabb ,

Doctor Juliet Gray ,

Doctor Sean Lim ,

Doctor Ellen Copson ,

Professor Graham Packham

Sponsor: Cancer Research UK

Chowdhury CCLG markers in paediatric tumour samples

Researchers:

Doctor Juliet Gray

Sponsor: Childrens Cancer and Leukaemia Group

Evaluating the efficacy of combination epigenetic and differentiation therapies for the treatment of high-risk neuroblastoma

Researchers:

Doctor Zoë Walters

Doctor Juliet Gray

Sponsor: Neuroblastoma UK

Beers CRUK C34592/A18518 Combining TLR agonists with LOB7/4 anti-CD40 mAb in neuroblastoma and lymphoma

Researchers:

Professor Stephen Beers

Doctor Juliet Gray

Sponsor: Cancer Research UK

Cancer Research UK Southampton Centre

Researchers:

Professor Peter Johnson

Professor Diana Eccles ,

Professor Tim Underwood ,

Professor Stephen Beers ,

Professor Jon Strefford ,

Doctor Jeremy Blaydes ,

Professor Edd James ,

Professor John Primrose ,

Professor Gareth Thomas ,

Professor Ramsey Cutress ,

Professor Francesco Forconi ,

Professor Freda Stevenson ,

Professor Alex Mirnezami ,

Professor Mark Cragg ,

Professor Aymen Al-Shamkhani ,

Professor Anneke Lucassen ,

Professor Simon Crabb ,

Doctor Juliet Gray ,

Doctor Sean Lim ,

Doctor Ellen Copson ,

Professor Graham Packham

Sponsor: Cancer Research UK

F Chowdhury CCUK Pilot Study: Immune monitoring in neuroblastoma patients receiving anti-GD2 monoclonal antibody therapy

Researchers:

Doctor Juliet Gray

Sponsor: Children with Cancer UK

External roles and responsibilities

Name: Member of Scientific Advisory Board, Solving Kids Cancer (External organisation)

Role: Member

Year: 2017 -

Name: Member of Executive Commitee European Neuroblastom Reseach Network (SIOPEN) (External organisation)

Role: Member

Year: 2015 - 2019

Name: Member of NCRI Childhood Cancer Leukaemia Clinical Study Group (External organisation)

Role: Member

Year: 2017 -

Name: Member of CRUK Protocol Safety Review Board (External organisation)

Role: Member

Year: 2016 -

Name: Invited expert to NICE Single Technology Appraisal Committee (Anti-GD2 in neuroblastoma) (External organisation)

Role: Member

Year: 2016 - 2018

Name: Chair of NCRI CG Neuroblastoma subgroup (External organisation)

Role: Chair

Year: 2018 -

Name: Member of national paediatric Experimental Cancer Medicine Centre Steering Group (External organisation)

Role: Member

Year: 2017 -

Name: SIOPEN European Neuroblastoma Research Network, Chair of Clinical Trials Committee (External organisation)

Role: Chair

Year: 2020 -

Name: Irish Cancer Society (External organisation)

Role: Member

Year: 2020

Name: Neuroblastoma Australia - member of Scientific Advisory Board (External organisation)

Role: Chair

Year: 2019 -

Doctor Juliet Gray

Research interests

Connect with Juliet

Research

Research groups

Research interests

Research projects

Active projects

Completed projects

Publications

Supervision

Current PhD Students

External roles and responsibilities

Biography

Prizes